Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Humans

Last updated: June 12, 2026
Sponsor: Deepak C. D'Souza
Overall Status: Active - Recruiting

Phase

1

Condition

Depression

Treatment

DMT-Medium Dose

DMT-Low Dose

THC-Low Dose

Clinical Study ID

NCT06671977
2000034770
  • Ages 21-65
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The goal of this phase 1 study is to investigate the safety and efficacy of dimethyltryptamine (DMT) in individuals with depression and healthy controls. We hypothesize that administration of DMT will result in decreases in depression, associated symptoms, and neuroplastic changes in depressed subjects. We expect that DMT will induce changes in neuroplasticity as indexed using electroencephalographic (EEG) measures and tasks in both depressed individuals and healthy volunteers, though to different degrees. These neuronal changes may in parallel cause changes in mood measured both in healthy and depressed subjects, which will be captured using appropriate psychometric measures of mood.

Eligibility Criteria

Inclusion

Some Common Inclusion Criteria:

  1. Males and females

  2. Age 21 to 65 years

  3. Body mass index between 18-35 kg/m2

  4. Willing to refrain from taking any medications not approved by the study physician

  5. Willing to refrain from using street drugs and alcohol

  6. Negative urine drug screen

  7. Willing and able to abstain from smoking throughout each test session

  8. Women who are of child-bearing potential (WOCBP) and sexually active must be willingto practice an effective means of birth control

  9. Willing not to drive to and from the testing session

Some Inclusion Criteria for Subjects with MDD:

  1. Diagnosed with Major Depressive Disorder (MDD)

  2. Unsatisfactory response to antidepressants

  3. Engaged in treatment for depression with a clinician and willing to continuetreatment for the duration of the study

  4. Not engaged in treatment

  5. Consent to allow the research team to communicate with mental health provider.

  6. Only subjects who get support for participation in the trial from their mentalhealth clinician will be eligible to be enrolled in the study

Exclusion

Some Common Exclusion Criteria:

  1. Medications that might significantly interfere with the effects of the studymedications

  2. Cognitive dysfunction that could interfere with study participation

  3. Alcohol or substance use disorder

  4. Any lifetime history of hallucinogen use disorder

  5. Regular use or misuse of hallucinogens

  6. History of intolerance to perceptual altering drugs

  7. Significant blood pressure problems

  8. Pregnancy or currently breast feeding (lactation)

  9. Any unstable medical conditions

  10. Significant cardiovascular disease

  11. Significantly abnormal laboratory test results

  12. History of serotonin syndrome

Some Exclusion criteria for MDD subjects:

  1. Current primary psychiatric disorder other than MDD

  2. Medically significant condition rendering unsuitability for the study

Some Exclusion criteria for healthy controls:

  1. No current DSM-V psychiatric disorder, excluding nicotine and caffeine use disorder

  2. No family history of serious mental illness (e.g., schizophrenia, bipolar disorder)

Some Inclusion criteria for healthy controls:

  1. No current DSM-5 psychiatric disorder, excluding nicotine and caffeine use disorder

  2. No lifetime use of psychiatric medication >3 months (proxy for psychiatricdisorders)

Study Design

Total Participants: 60
Treatment Group(s): 4
Primary Treatment: DMT-Medium Dose
Phase: 1
Study Start date:
March 14, 2025
Estimated Completion Date:
December 01, 2027

Connect with a study center

  • Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine,

    West Haven, Connecticut 06516
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.